Quest Diagnostics Inc Restructuring Charges
Quest Diagnostics Inc (DGX) reported Restructuring Charges of $6.00 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-10-21.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2025-10-21
- Quest Diagnostics Inc restructuring charges for the quarter ending 2025-09-30 was $6.00M, a 14.29% decline year-over-year.
- Quest Diagnostics Inc restructuring charges for the quarter ending 2025-06-30 was $1.00M, a 87.50% decline year-over-year.
- Quest Diagnostics Inc restructuring charges for the quarter ending 2024-09-30 was $7.00M, a 600.00% increase year-over-year.
- Quest Diagnostics Inc restructuring charges for the quarter ending 2024-06-30 was $8.00M, a 700.00% increase year-over-year.
- Quest Diagnostics Inc restructuring charges for fiscal 2022 was $55.00M, a 323.08% increase from fiscal 2021.
- Quest Diagnostics Inc restructuring charges for fiscal 2021 was $13.00M, a 7.14% decline from fiscal 2020.
- Quest Diagnostics Inc restructuring charges for fiscal 2020 was $14.00M.
- Quest Diagnostics Inc restructuring charges for fiscal 2019 was -$3.00M, a 106.12% decline from fiscal 2018.
| Period end | Restructuring Charges 3 month | Restructuring Charges 3 month as first filed | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|---|
| 2025-09-30 | $6.00M 10-Q · filed 2025-10-21 | $7.00M derived: sum of 2 quarters · filed 2025-10-21 | $18.00M 10-Q · filed 2025-10-21 | ||
| 2025-06-30 | $1.00M 10-Q · filed 2025-07-23 | $12.00M 10-Q · filed 2025-07-23 | |||
| 2024-09-30 | $7.00M 10-Q · filed 2025-10-21 | $15.00M derived: sum of 2 quarters · filed 2025-10-21 | $21.00M 10-Q · filed 2025-10-21 | ||
| 2024-06-30 | $8.00M 10-Q · filed 2025-07-23 | $14.00M 10-Q · filed 2025-07-23 | |||
| 2023-09-30 | $1.00M 10-Q · filed 2024-10-23 | $2.00M derived: sum of 2 quarters · filed 2024-10-23 | $17.00M 10-Q · filed 2024-10-23 | ||
| 2023-06-30 | $1.00M 10-Q · filed 2024-07-24 | $16.00M 10-Q · filed 2024-07-24 | |||
| 2022-12-31 | $55.00M 10-K · filed 2023-02-21 | ||||
| 2021-12-31 | $13.00M 10-K · filed 2023-02-21 | ||||
| 2020-12-31 | $14.00M 10-K · filed 2021-02-22 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $0.00 derived: sum of 2 quarters · filed 2021-02-22 | $0.00 derived: sum of 3 quarters · filed 2021-02-22 | -$3.00M 10-K · filed 2021-02-22 | |
| 2019-09-30 | $0.00 10-Q · filed 2019-10-23 | $0.00 derived: sum of 2 quarters · filed 2019-10-23 | -$3.00M 10-Q · filed 2019-10-23 | $23.00M derived: sum of 4 quarters · filed 2020-02-20 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-07-24 | -$3.00M 10-Q · filed 2019-07-24 | $23.00M derived: sum of 3 quarters · filed 2020-02-20 | $27.00M derived: sum of 4 quarters · filed 2020-02-20 | |
| 2019-03-31 | -$3.00M 10-Q · filed 2019-04-24 | $23.00M derived: sum of 2 quarters · filed 2020-02-20 | $27.00M derived: sum of 3 quarters · filed 2020-02-20 | $34.00M derived: sum of 4 quarters · filed 2020-02-20 | |
| 2018-12-31 | $26.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $30.00M derived: sum of 2 quarters · filed 2020-02-20 | $37.00M derived: sum of 3 quarters · filed 2020-02-20 | $49.00M 10-K · filed 2020-02-20 | |
| 2018-09-30 | $4.00M 10-Q · filed 2019-10-23 | $11.00M derived: sum of 2 quarters · filed 2019-10-23 | $23.00M 10-Q · filed 2019-10-23 | $42.00M derived: sum of 4 quarters · filed 2019-10-23 | |
| 2018-06-30 | $7.00M 10-Q · filed 2019-07-24 | $19.00M 10-Q · filed 2019-07-24 | $38.00M derived: sum of 3 quarters · filed 2019-07-24 | $43.00M derived: sum of 4 quarters · filed 2019-07-24 | |
| 2018-03-31 | $12.00M 10-Q · filed 2019-04-24 | $31.00M derived: sum of 2 quarters · filed 2019-04-24 | $36.00M derived: sum of 3 quarters · filed 2019-04-24 | $39.00M derived: sum of 4 quarters · filed 2019-04-24 | |
| 2017-12-31 | $19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-21 | $24.00M derived: sum of 2 quarters · filed 2019-02-21 | $27.00M derived: sum of 3 quarters · filed 2019-02-21 | $30.00M 10-K · filed 2019-02-21 | |
| 2017-09-30 | $5.00M 10-Q · filed 2018-10-24 | $8.00M derived: sum of 2 quarters · filed 2018-10-24 | $11.00M 10-Q · filed 2018-10-24 | ||
| 2017-06-30 | $3.00M 10-Q · filed 2018-07-25 | $6.00M 10-Q · filed 2018-07-25 | |||
| 2016-12-31 | $11.00M 10-K · filed 2018-02-23 | ||||
| 2015-12-31 | $39.00M 10-K · filed 2017-02-22 | ||||
| 2014-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $25.00M derived: sum of 2 quarters · filed 2016-02-26 | $52.00M derived: sum of 3 quarters · filed 2016-02-26 | $43.00M 10-K · filed 2016-02-26 | |
| 2014-09-30 | $16.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $43.00M derived: sum of 2 quarters · filed 2014-10-30 | $34.00M 10-Q · filed 2014-10-30 | $180.60M derived: sum of 4 quarters · filed 2015-02-24 | |
| 2014-06-30 | $27.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $18.00M 10-Q · filed 2014-07-31 | $164.60M derived: sum of 3 quarters · filed 2015-02-24 | $135.60M derived: sum of 4 quarters · filed 2015-02-24 | |
| 2014-03-31 | -$9.00M 10-Q · filed 2014-05-01 | $137.60M derived: sum of 2 quarters · filed 2015-02-24 | $108.60M derived: sum of 3 quarters · filed 2015-02-24 | $31.00M derived: sum of 4 quarters · filed 2015-02-24 | |
| 2013-12-31 | $146.60M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $117.60M derived: sum of 2 quarters · filed 2015-02-24 | $40.00M derived: sum of 3 quarters · filed 2015-02-24 | $75.00M 10-K · filed 2015-02-24 | |
| 2013-09-30 | -$29.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-24 | -$106.60M derived: sum of 2 quarters · filed 2013-10-24 | -$71.60M 10-Q · filed 2013-10-24 | ||
| 2013-06-30 | -$77.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-25 | -$42.60M 10-Q · filed 2013-07-25 | |||
| 2013-03-31 | $35.00M 10-Q · filed 2014-05-01 | -$33.60M 10-Q · filed 2013-04-24 | |||
| 2009-09-30 | $0.00 10-Q · filed 2009-10-27 | ||||
| 2008-09-30 | $72.65M 10-Q · filed 2009-10-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |